Keywords: scil, tech, reports, positive, preclinical, data, st01

Scil Tech reports positive preclinical data for ST01

Article | 04 July 2005

Martinsreid, Germany-based Scil Technology, a biopharmaceutical company which focuses on the development of dental and orthopedic tissue regeneration products, says ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing